The new Green Deal will have a direct impact on the ongoing negotiations about the post-2020 Common Agricultural Policy (CAP) as EU farmers will be asked to re-adjust the way they work to the new green objectives.
The discussion over the future of biotechnology in Europe heated up after the EU Court ruled in July last year that gene editing should, in principle, fall under the GMO Directive. We focus on the future of biotechnology in Europe, the regulatory framework of the so-called new plant-breeding techniques, as well as GMOs.
The next European Parliament and Commission will have to deal with a number of important issues related to the future of the European agricultural sector.
Download PDF
New plant breeding techniques (NPBTs) emerged as an innovative agricultural solution in the last decade, allowing the development of new plant varieties by modifying the DNA of the seeds and plant cells.
The EU ban on animal testing for cosmetic products came into force in 2013, although testing is still allowed in Europe for healthcare products and pharmaceuticals, as well as some chemicals and food.
The re-authorisation of Monsanto’s weedkiller glyphosate and the ban of three neonicotinoids – a class of insecticide – have opened a heated debate on the role of science in policy-making.
